多品种结构抗风险
Search documents
华绿生物:鹿茸菇改建项目正在按计划推进
Zheng Quan Ri Bao· 2025-10-29 09:15
Core Viewpoint - The company has stable production of enoki mushrooms, but product prices are influenced by various factors, leading to uncertainty [2] Group 1 - The company is progressing as planned on the reformation project for deer antler mushrooms, expecting to achieve full production by the end of the year [2] - A diversified product structure is anticipated to enhance the company's ability to withstand risks [2]
华绿生物:鹿茸菇改建项目正在按计划推进,预计年末实现满产
Mei Ri Jing Ji Xin Wen· 2025-10-29 00:50
Core Viewpoint - The company has experienced continuous revenue growth in recent years, but net profit has shown significant volatility, with a projected loss in 2024 followed by a turnaround in the first three quarters of 2025 [1] Group 1: Revenue and Profitability - The company's enoki mushroom production remains stable, but product prices are influenced by various factors, leading to uncertainty [1] - The company is expected to achieve full production capacity for the restructured deer antler mushroom production line by the end of the year, which will enhance its ability to withstand market risks [1] Group 2: Cost Management and Future Outlook - The company plans to implement reasonable production schedules for new projects to quickly reach full production and reduce unit production costs [1] - The company is closely monitoring changes in raw material markets and is committed to controlling raw material costs, which have remained generally stable in recent years [1]